We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNY icon
426
Sanofi
SNY
$109B
$2.62M 0.03%
51,232
+51,212
+256,060% +$2.49M
TTE icon
427
TotalEnergies
TTE
$193B
$2.61M 0.03%
67,813
+67,727
+78,752% +$2.51M
ETR icon
428
Entergy
ETR
$51B
$2.59M 0.03%
55,228
-92,748
-63% -$4.5M
SWK icon
429
Stanley Black & Decker
SWK
$14.6B
$2.58M 0.03%
18,534
-65,184
-78% -$7.86M
WMT icon
430
Walmart Inc
WMT
$908B
$2.58M 0.03%
64,506
-57,753
-47% -$2.38M
KR icon
431
Kroger
KR
$36.7B
$2.55M 0.03%
75,450
-33
-0% -$1.07K
SCHW
432
Charles Schwab
SCHW
$184B
$2.5M 0.03%
74,029
-11,097
-13% -$397K
PSX icon
433
Phillips 66
PSX
$83.7B
$2.5M 0.03%
34,728
-14,921
-30% -$1.06M
PRNB
434
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$2.49M 0.03%
41,658
-9,342
-18% -$577K
CLX icon
435
Clorox
CLX
$12B
$2.48M 0.03%
11,284
-309
-3% -$61.7K
IP icon
436
International Paper
IP
$22.7B
$2.47M 0.03%
74,172
+65,467
+752% +$2.08M
AVY icon
437
Avery Dennison
AVY
$12.8B
$2.46M 0.03%
21,598
+18,061
+511% +$1.98M
GWW icon
438
W.W. Grainger
GWW
$64.4B
$2.43M 0.03%
7,743
-1,792
-19% -$518K
INFO
439
DELISTED
IHS Markit Ltd. Common Shares
INFO
$2.39M 0.03%
31,687
-10,742
-25% -$731K
PEG icon
440
Public Service Enterprise Group
PEG
$38.8B
$2.36M 0.02%
47,995
-19,978
-29% -$996K
EQR icon
441
Equity Residential
EQR
$25.8B
$2.34M 0.02%
39,772
-9,969
-20% -$618K
CPRT icon
442
Copart
CPRT
$29B
$2.34M 0.02%
112,196
-41,768
-27% -$838K
WDAY icon
443
Workday
WDAY
$42B
$2.32M 0.02%
12,395
-774
-6% -$125K
CWST icon
444
Casella Waste Systems
CWST
$5.83B
$2.32M 0.02%
+44,475
New +$2.12M
B
445
Barrick Mining
B
$61B
$2.31M 0.02%
85,982
-3,968
-4% -$99.1K
SJR
446
DELISTED
Shaw Communications Inc.
SJR
$2.27M 0.02%
139,803
-287,287
-67% -$4.74M
CNC icon
447
Centene
CNC
$30.5B
$2.21M 0.02%
34,752
+571
+2% +$37.2K
TWLO icon
448
Twilio
TWLO
$29B
$2.21M 0.02%
10,054
+369
+4% +$59.2K
FTV icon
449
Fortive
FTV
$18B
$2.2M 0.02%
51,567
-274,397
-84% -$10.7M
ERIC icon
450
Ericsson
ERIC
$32.5B
$2.17M 0.02%
233,742
+83,096
+55% +$721K

Similar funds

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.